hydroperoxyisophosphamide has been researched along with mesna in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allenbacher, A; Botzler, C; Issels, R; Meier, T; Mueller, E; Multhoff, G; Wiesnet, M | 1 |
Issels, RD; Meier, TH; Müller, E; Multhoff, G; Wilmanns, W | 1 |
Apfel, R; Bogdahn, U; Dekant, A; Jäger, AH; Pfeufer, B | 1 |
Beck-Schimmer, B; Biber, J; Hernando, N; Murer, H; Patzer, L; Ziegler, U | 1 |
4 other study(ies) available for hydroperoxyisophosphamide and mesna
Article | Year |
---|---|
Ifosfamide induced depletion of glutathione in human peripheral blood lymphocytes and protection by mesna.
Topics: Acetaldehyde; Acrolein; Animals; CHO Cells; Cricetinae; Glutathione; Humans; Ifosfamide; Intracellular Fluid; Lymphocytes; Mesna | 1994 |
Ifosfamide induced stress response in human lymphocytes.
Topics: Blotting, Western; Cells, Cultured; DNA; Glutathione; Heat-Shock Proteins; Humans; Ifosfamide; Interleukin-2; Isoelectric Focusing; Kinetics; Lymphocyte Activation; Lymphocytes; Mesna; Recombinant Proteins; Stress, Physiological; Thymidine | 1993 |
In vitro studies on interaction of 4-hydroperoxyifosfamide and 2-mercaptoethanesulphonate in malignant gliomas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Interactions; Drug Screening Assays, Antitumor; Glioma; Humans; Ifosfamide; Mesna; Models, Biological; Tumor Cells, Cultured | 1993 |
Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
Topics: Acetaldehyde; Animals; Antineoplastic Agents, Alkylating; Biological Transport; Cell Death; Cell Line; Dose-Response Relationship, Drug; Gene Expression Regulation; Ifosfamide; Kidney; Mesna; Opossums; Phosphates; Phosphoramide Mustards; RNA, Messenger; Sodium-Phosphate Cotransporter Proteins, Type IIa | 2006 |